A share price of AlloVir Inc [ALVR] is currently trading at $0.78, up 0.62%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALVR shares have gain 3.91% over the last week, with a monthly amount drifted -2.59%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
AlloVir Inc [NASDAQ: ALVR] stock has seen the most recent analyst activity on December 26, 2023, when BofA Securities downgraded its rating to a Underperform and also revised its price target to $1 from $17. Previously, Piper Sandler downgraded its rating to Neutral on December 22, 2023. On December 22, 2023, downgrade downgraded it’s rating to Market Perform. JP Morgan downgraded its rating to a Underweight. BofA Securities initiated its recommendation with a Buy and recommended $17 as its price target on August 18, 2023. In a note dated August 24, 2020, SVB Leerink initiated an Outperform rating and provided a target price of $41 on this stock.
AlloVir Inc experienced fluctuations in its stock price throughout the past year between $0.58 and $3.45. AlloVir Inc [NASDAQ: ALVR] shares were valued at $0.78 at the most recent close of the market.
Analyzing the ALVR fundamentals
Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -14.43%, Pretax Profit Margin comes in at -16.76%, and Net Profit Margin reading is -16.75%. To continue investigating profitability, this company’s Return on Assets is posted at -1.07, Equity is -0.96 and Total Capital is -0.94. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7562 points at the first support level, and at 0.7331 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8012, and for the 2nd resistance point, it is at 0.8231.
Ratios To Look Out For
To put it in perspective, the Current Ratio for AlloVir Inc [NASDAQ:ALVR] is 55.08. Also, the Quick Ratio is 55.08, while the Cash Ratio stands at 44.4.
Transactions by insiders
Recent insider trading involved Brainard Diana, Chief Executive Officer, that happened on Aug 20 ’24 when 5390.0 shares were sold. Officer, Brainard Diana completed a deal on Aug 20 ’24 to buy 5390.0 shares. Meanwhile, General Counsel Miller Edward sold 422.0 shares on Aug 19 ’24.
